M

Active Director Director DIN 07417143
DIN 07417143 First appointment Feb 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Meenakshi

Data last updated:

Meenakshi is a Director at Genostic Pharma Private Limited (since 2016). The company operates in Chemicals. Genostic Pharma Private Limited reported revenue of ₹81.7 Lakh (FY 2025).

DIN 07417143
Primary Designation Director
Industry Chemicals
First Appointment 17 Feb 2016
Oldest Company Age 10 yrs
Largest company Genostic Pharma Private Limited · ₹81.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genostic Pharma Private Limited U24231HR2016PTC058261
Director17 Feb 20162016₹81.7 Lakh (FY 2025)Active

Board colleagues of Meenakshi

NameDINCompanyDesignation
Parveen Kumar07418313Genostic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genostic Pharma Private Limited
Premium access

Shareholding and investment profile for Meenakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenakshi

Meenakshi currently holds 1 directorship: Genostic Pharma Private Limited (Director, since 17 Feb 2016, revenue ₹81.7 Lakh (FY 2025)).

Meenakshi was first appointed on 17 Feb 2016 as Director at Genostic Pharma Private Limited.

The current boards of Meenakshi's companies include Parveen Kumar (Genostic Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available